Mayne Pharma | MYX - Ebitda

株価
2.35
毎日の変更
0.10 4.44%
毎月
-7.11%
毎年
-67.50%
Q1 予測
2.15




Ebitda 変化する 日付
Ansell USD 185.8M 7M 2025-12
Avita Medical AUD -9.69M 12.21M 2025-12
Cochlear AUD 306.4M 13.5M 2025-12
CSL USD 3.13B 1.17B 2025-12
Healius AUD 74.9M 40.3M 2025-06
Integral Diagnostics AUD 46.27M 3.52M 2024-06
Medical Developments International AUD 1.78M 3.78M 2024-12
Nanosonics AUD 12.49M 1.13M 2025-12
Polynovo AUD 3.89M 100K 2025-12
Ramsay Health Care AUD 1.12B 10.6M 2025-12
ResMed USD 547.48M 27.46M 2025-12
Sigma Healthcare AUD 19.96M 5.15M 2024-07
Sonic Healthcare AUD 839.07M 51.09M 2024-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12